Serum c-erb B-2 in Breast Cancer Patients

References

• Weiss R A, Marshall C J. Oncogenes. Lancet 1984; 2: 1138–42
   PubMed Web of Science ®Google Scholar
• Bargmann C I, Hung M C, Weinberg R A. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 1986; 319: 226–30
   PubMed Web of Science ®Google Scholar
• Schecter A L, Stern D F, Vaidyanathan L. The neu oncogene: an erbB-related gene encoding a 185–000-Mr tumor antigen. Nature 1984; 312: 513–6
   PubMed Web of Science ®Google Scholar
• Slamon D J, Clark G M, Wong S G, Levin W J, Ullrich A, Maguire W L. Human breast cancer correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177–82
   PubMed Web of Science ®Google Scholar
• Slamon D J, Godolphin W, Jones L A. Studies of the HER-2/nue proto-oncogene in human breast and ovarian cancer. Science 1989; 244: 707–12
   PubMed Web of Science ®Google Scholar
• Akiyama T, Sudo C, Ogawa H, Toyoshima K, Yamamoto T. The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 1986; 232: 1644–6
   PubMed Web of Science ®Google Scholar
• Mori S, Mori Y, Mukaiyama T. In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cells. Jpn J Cancer 1990; 81: 489–94
   PubMedGoogle Scholar
• Langton B C, Crenshaw M C, Chao L A, Stuart S G, Akita R W, Jackson J E. An antigen immunologically related to the external domain of gp185 is shed from nude mouse tumors overexpressing the c-erbB-2 (HER/neu) oncogene. Cancer Res 1991; 15: 2593–8
   Google Scholar
• Leitzel K, Teramoto Y, Sampson E. Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients. J Clin Oncol 1992; 9: 1436–43
   Google Scholar
• Chan D W, Thornton P L. AIA-1200 immunoassay system. Immunoassay automation: a practical guide, D W Chaw. Academic Press, San Diego 1992; 95–115
   Google Scholar
• Tobias R, Rothwell C, Wagner J, Green A, Liu Y SV. Development and evaluation of a radioimmunoassay for the detection of a monoclonal antibody defined breast tumor associated antigen 115D8/DF3. Clin Chem 1985; 31: 986
   Web of Science ®Google Scholar
• Smirnov N. On the estimation of the maximum terms in a series of observations. Dokl Akad Nauk SSSR 1941; 33: 346–50
   Google Scholar
• Grubbs F E. Sample criteria for testing outlying observations. Ann Math Stat 1950; 21: 27–58
   Google Scholar
• Kraus M H, Popescu N C, Amsbaugh S C, King C R. Overex-pression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 1987; 6: 605–10
   PubMed Web of Science ®Google Scholar
• Venter D J, Tuzi N L, Kumar S, Gullick W J. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas immunohistological assessment correlates with gene amplification. Lancet 1987; 2: 69–71
   PubMed Web of Science ®Google Scholar
• Zhou D, Battifora H, Yokota J, Yamamoto T, Cline M J. Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. Cancer Res 1987; 47: 6123–5
   PubMed Web of Science ®Google Scholar
• Gusterson B A, Machin L G, Gullick W J. C-erbB-2 expression in benign and malignant breast disease. Br J Cancer 1988; 58: 453–7
   PubMed Web of Science ®Google Scholar
• Wright C, Angus B, Nicholson S. Expression of c-erbB-2 oncoprotein a prognostic indicator in human breast cancer. Cancer Res 1989; 49: 2087–90
   PubMed Web of Science ®Google Scholar
• Gullick W J, Love S B, Wright C. C-erbB-2 overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer 1991; 63: 434–8
   PubMed Web of Science ®Google Scholar
• Winstanley J, Cooke T, Murray G D. The long-term prognostic significance of c-erbB-2 in primary breast cancer. Br J Cancer 1991; 63: 447–50
   PubMed Web of Science ®Google Scholar
• Park J W, Stagg R, Lewis G D. Anti-185HER2 monoclonal antibodies; biological properties and potential for im-munotherapy. GenesOncogenes and hormones: advances in molecular biology of breast cancer, M E Lippman, R B Dickson. Kluwer, Boston 1991; 193–211
   Google Scholar